Risk of malignancy index validity assessment in premenopausal and postmenopausal women with adnexal tumors

Milan Terzic, Jelena Dotlic, Ivana Likic, Natasa Brndusic, Igor Pilic, Nebojsa Ladjevic, Sanja Maricic, Nebojsa Arsenovic, Zoran Maricic

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective: The aim of this study was to investigate the validity of the risk of malignancy index (RMI) in premenopausal and postmenopausal patients with adnexal masses. Materials and Methods: The study involved all women treated for adnexal tumors throughout an 18-month period in the Clinic for Gynecology and Obstetrics, Clinical Center of Serbia (Belgrade, Serbia). On admission, detailed anamnestic and laboratory data were obtained and an expert ultrasound scan was performed. The RMI was calculated for all patients and the obtained data were related to histopathological findings of the tumors. For statistical analysis, we used descriptive and analytical statistics methods and an SPSS computer program. Results: From a total number of 540 women, 85 women had malignant tumors; 20 women, borderline tumors; and 435 women, benign adnexal tumors. The RMI was reliable in 84.6% of all patients; in 77% of premenopausal patients, and in 81.1% of postmenopausal patients. The sensitivity of the RMI in the overall population was 83.81%; the specificity was 77.24%; the positive predictive value (PPV) was 47.06%, and the negative predictive value (NPV) was 95.18%. In premenopausal women, the RMI sensitivity was 83.87%; specificity, 80.31%; PPV, 28.89%; and NPV, 98.12%. In postmenopausal women the RMI sensitivity was 83.78%; specificity, 68.18%; PPV, 63.92%; and NPV, 74.71%. Conclusion: The RMI was a reliable factor for differentiating benign from malignant adnexal masses in premenopausal and postmenopausal patients.

Original languageEnglish
Pages (from-to)253-257
Number of pages5
JournalTaiwanese Journal of Obstetrics and Gynecology
Volume52
Issue number2
DOIs
Publication statusPublished - Jun 1 2013
Externally publishedYes

Fingerprint

Neoplasms
Serbia
Gynecology
Obstetrics
Software
Population

Keywords

  • Adnexal masses
  • Postmenopause
  • Premenopause
  • Risk of malignancy index

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Risk of malignancy index validity assessment in premenopausal and postmenopausal women with adnexal tumors. / Terzic, Milan; Dotlic, Jelena; Likic, Ivana; Brndusic, Natasa; Pilic, Igor; Ladjevic, Nebojsa; Maricic, Sanja; Arsenovic, Nebojsa; Maricic, Zoran.

In: Taiwanese Journal of Obstetrics and Gynecology, Vol. 52, No. 2, 01.06.2013, p. 253-257.

Research output: Contribution to journalArticle

Terzic, M, Dotlic, J, Likic, I, Brndusic, N, Pilic, I, Ladjevic, N, Maricic, S, Arsenovic, N & Maricic, Z 2013, 'Risk of malignancy index validity assessment in premenopausal and postmenopausal women with adnexal tumors', Taiwanese Journal of Obstetrics and Gynecology, vol. 52, no. 2, pp. 253-257. https://doi.org/10.1016/j.tjog.2013.04.017
Terzic, Milan ; Dotlic, Jelena ; Likic, Ivana ; Brndusic, Natasa ; Pilic, Igor ; Ladjevic, Nebojsa ; Maricic, Sanja ; Arsenovic, Nebojsa ; Maricic, Zoran. / Risk of malignancy index validity assessment in premenopausal and postmenopausal women with adnexal tumors. In: Taiwanese Journal of Obstetrics and Gynecology. 2013 ; Vol. 52, No. 2. pp. 253-257.
@article{982dc491845f4c2c8ce135218064865c,
title = "Risk of malignancy index validity assessment in premenopausal and postmenopausal women with adnexal tumors",
abstract = "Objective: The aim of this study was to investigate the validity of the risk of malignancy index (RMI) in premenopausal and postmenopausal patients with adnexal masses. Materials and Methods: The study involved all women treated for adnexal tumors throughout an 18-month period in the Clinic for Gynecology and Obstetrics, Clinical Center of Serbia (Belgrade, Serbia). On admission, detailed anamnestic and laboratory data were obtained and an expert ultrasound scan was performed. The RMI was calculated for all patients and the obtained data were related to histopathological findings of the tumors. For statistical analysis, we used descriptive and analytical statistics methods and an SPSS computer program. Results: From a total number of 540 women, 85 women had malignant tumors; 20 women, borderline tumors; and 435 women, benign adnexal tumors. The RMI was reliable in 84.6{\%} of all patients; in 77{\%} of premenopausal patients, and in 81.1{\%} of postmenopausal patients. The sensitivity of the RMI in the overall population was 83.81{\%}; the specificity was 77.24{\%}; the positive predictive value (PPV) was 47.06{\%}, and the negative predictive value (NPV) was 95.18{\%}. In premenopausal women, the RMI sensitivity was 83.87{\%}; specificity, 80.31{\%}; PPV, 28.89{\%}; and NPV, 98.12{\%}. In postmenopausal women the RMI sensitivity was 83.78{\%}; specificity, 68.18{\%}; PPV, 63.92{\%}; and NPV, 74.71{\%}. Conclusion: The RMI was a reliable factor for differentiating benign from malignant adnexal masses in premenopausal and postmenopausal patients.",
keywords = "Adnexal masses, Postmenopause, Premenopause, Risk of malignancy index",
author = "Milan Terzic and Jelena Dotlic and Ivana Likic and Natasa Brndusic and Igor Pilic and Nebojsa Ladjevic and Sanja Maricic and Nebojsa Arsenovic and Zoran Maricic",
year = "2013",
month = "6",
day = "1",
doi = "10.1016/j.tjog.2013.04.017",
language = "English",
volume = "52",
pages = "253--257",
journal = "Taiwanese Journal of Obstetrics and Gynecology",
issn = "1028-4559",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Risk of malignancy index validity assessment in premenopausal and postmenopausal women with adnexal tumors

AU - Terzic, Milan

AU - Dotlic, Jelena

AU - Likic, Ivana

AU - Brndusic, Natasa

AU - Pilic, Igor

AU - Ladjevic, Nebojsa

AU - Maricic, Sanja

AU - Arsenovic, Nebojsa

AU - Maricic, Zoran

PY - 2013/6/1

Y1 - 2013/6/1

N2 - Objective: The aim of this study was to investigate the validity of the risk of malignancy index (RMI) in premenopausal and postmenopausal patients with adnexal masses. Materials and Methods: The study involved all women treated for adnexal tumors throughout an 18-month period in the Clinic for Gynecology and Obstetrics, Clinical Center of Serbia (Belgrade, Serbia). On admission, detailed anamnestic and laboratory data were obtained and an expert ultrasound scan was performed. The RMI was calculated for all patients and the obtained data were related to histopathological findings of the tumors. For statistical analysis, we used descriptive and analytical statistics methods and an SPSS computer program. Results: From a total number of 540 women, 85 women had malignant tumors; 20 women, borderline tumors; and 435 women, benign adnexal tumors. The RMI was reliable in 84.6% of all patients; in 77% of premenopausal patients, and in 81.1% of postmenopausal patients. The sensitivity of the RMI in the overall population was 83.81%; the specificity was 77.24%; the positive predictive value (PPV) was 47.06%, and the negative predictive value (NPV) was 95.18%. In premenopausal women, the RMI sensitivity was 83.87%; specificity, 80.31%; PPV, 28.89%; and NPV, 98.12%. In postmenopausal women the RMI sensitivity was 83.78%; specificity, 68.18%; PPV, 63.92%; and NPV, 74.71%. Conclusion: The RMI was a reliable factor for differentiating benign from malignant adnexal masses in premenopausal and postmenopausal patients.

AB - Objective: The aim of this study was to investigate the validity of the risk of malignancy index (RMI) in premenopausal and postmenopausal patients with adnexal masses. Materials and Methods: The study involved all women treated for adnexal tumors throughout an 18-month period in the Clinic for Gynecology and Obstetrics, Clinical Center of Serbia (Belgrade, Serbia). On admission, detailed anamnestic and laboratory data were obtained and an expert ultrasound scan was performed. The RMI was calculated for all patients and the obtained data were related to histopathological findings of the tumors. For statistical analysis, we used descriptive and analytical statistics methods and an SPSS computer program. Results: From a total number of 540 women, 85 women had malignant tumors; 20 women, borderline tumors; and 435 women, benign adnexal tumors. The RMI was reliable in 84.6% of all patients; in 77% of premenopausal patients, and in 81.1% of postmenopausal patients. The sensitivity of the RMI in the overall population was 83.81%; the specificity was 77.24%; the positive predictive value (PPV) was 47.06%, and the negative predictive value (NPV) was 95.18%. In premenopausal women, the RMI sensitivity was 83.87%; specificity, 80.31%; PPV, 28.89%; and NPV, 98.12%. In postmenopausal women the RMI sensitivity was 83.78%; specificity, 68.18%; PPV, 63.92%; and NPV, 74.71%. Conclusion: The RMI was a reliable factor for differentiating benign from malignant adnexal masses in premenopausal and postmenopausal patients.

KW - Adnexal masses

KW - Postmenopause

KW - Premenopause

KW - Risk of malignancy index

UR - http://www.scopus.com/inward/record.url?scp=84881025083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881025083&partnerID=8YFLogxK

U2 - 10.1016/j.tjog.2013.04.017

DO - 10.1016/j.tjog.2013.04.017

M3 - Article

VL - 52

SP - 253

EP - 257

JO - Taiwanese Journal of Obstetrics and Gynecology

JF - Taiwanese Journal of Obstetrics and Gynecology

SN - 1028-4559

IS - 2

ER -